Clinical Trial Update: Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC [NA]

View source ↗

Summary

Clinical trial update describing a study of super-hyperfractionation pulse radiotherapy combined with immune checkpoint inhibitors for advanced non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Lung Cancer, Immune Checkpoint Inhibitor | NA | Status: RECRUITING